(DMTK) – DermTech Shares Rise On Medicare Coverage For Skin Cancer Diagnostic Test

Shares of precision dermatology company DermTech Inc (NASDAQ: DMTK) are rallying Thursday after receiving Medicare coverage for its diagnostic test to rule out skin cancer. The California-based company said the Medicare Administrative Contractor Palmetto GBA MolDx issued a final local coverage determination for its Pigmented Lesion Assay, or PLA. The…